Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
Drug repositioning is the application of the existing drugs to new uses and has the potential to reduce the time and cost required for the typical drug discovery process. In this study, we repositioned thiopurine drugs used for the treatment of acute leukaemia as new tyrosinase inhibitors. Tyrosinas...
Main Authors: | Joonhyeok Choi, You-Mie Lee, Jun-Goo Jee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/19/1/77 |
Similar Items
-
Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors
by: Joonhyeok Choi, et al.
Published: (2015-12-01) -
Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis
by: Paula Sousa, et al.
Published: (2020-07-01) -
A drug‐repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6‐thioguanine as an effective therapeutic agent for TPMT‐low cancer cells
by: Inki Kim, et al.
Published: (2018-09-01) -
Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies
by: Isidro Palos, et al.
Published: (2017-06-01) -
A computational multi-targeting approach for drug repositioning for psoriasis treatment
by: Akachukwu Ibezim, et al.
Published: (2021-07-01)